Mood Stabilizers News and Research

RSS
Bristol-Myers Squibb first quarter net sales increase 5% to $3.3 billion

Bristol-Myers Squibb first quarter net sales increase 5% to $3.3 billion

Medication for depression ended before recommended time

Medication for depression ended before recommended time

Seaside Therapeutics reports positive data from STX209 Phase 2 study in fragile X syndrome

Seaside Therapeutics reports positive data from STX209 Phase 2 study in fragile X syndrome

Intellectually disabled in Victorian government run facilities treated in a “Victorian” manner

Intellectually disabled in Victorian government run facilities treated in a “Victorian” manner

Antidepressants and mood stabilizers may benefit stroke victims

Antidepressants and mood stabilizers may benefit stroke victims

Mood altering effects of Phenytoin

Mood altering effects of Phenytoin

New systematic study for managing treatment-resistant bipolar depression

New systematic study for managing treatment-resistant bipolar depression

Johnson & Johnson announces financial results for the third quarter of 2009

Johnson & Johnson announces financial results for the third quarter of 2009

Cephalon announces positive results from study of NUVIGIL in bipolar depression

Cephalon announces positive results from study of NUVIGIL in bipolar depression

New treatment approach needed for management of depression with bipolar disorder

New treatment approach needed for management of depression with bipolar disorder

Bipolar disorders linked to increased risk of early death from medical illness

Bipolar disorders linked to increased risk of early death from medical illness

Study identifies problems with diagnosis of bipolar disorder

Study identifies problems with diagnosis of bipolar disorder

Omega-3 fatty acids for bipolar disorder

Omega-3 fatty acids for bipolar disorder

New mouse model of bipolar disorder

New mouse model of bipolar disorder

Study suggests Risperidone long-acting injection combined with standard treatment helped delay time to relapse in patients with bipolar disorder

Study suggests Risperidone long-acting injection combined with standard treatment helped delay time to relapse in patients with bipolar disorder

Dramatic rise of bipolar disorder in young Americans

Dramatic rise of bipolar disorder in young Americans

Bipolar disorder a growing health issue

Bipolar disorder a growing health issue

Urgent need for better understanding of bipolar disease in children and adolescents

Urgent need for better understanding of bipolar disease in children and adolescents

Modafinil under study for bipolar disorder

Modafinil under study for bipolar disorder

Childhood-onset bipolar disorder is more common than believed

Childhood-onset bipolar disorder is more common than believed